Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/2557
Nаziv: | Epidemiological data of ovarian cancer in vojvodina and south great plain region in Hungary in 2007-2012 period: Crossbiomark IPA PROJECT HUSRB/1203/214/091 | Аutоri: | Aljoša Mandić Laszlo Thurzó Dejan Ninčić Milica Živaljević Tihomir Dugandžija Robert Berkecz |
Ključnе rеči: | Ovarian Neoplasm;Epidemiology;Neoplasm Staging | Dаtum izdаvаnjа: | 1-јан-2013 | Čаsоpis: | Archive of Oncology | Sažetak: | © 2013, Oncology Institute of Vojvodina, Sremska Kamenica. Background: Ovarian cancer is among the sixth leading cancers in Vojvodina and the fifth leading cause of cancer death among female population in Vojvodina according to Cancer Registry of Vojvodina in 2010. The majority of ovarian cancers cases are diagnosed at an advanced stage, FIGO stage III-IV with poor prognosis. The aim of the study was to evaluate newly diagnosed ovarian cancer among female population in Vojvodina (Serbia) and South Great Plain region in Hungary in 2007-2012 period. Methods: The evaluation was based on the data from hospital registries for malignant diseases at the Oncology Institute of Vojvodina and the Department of Oncotherapy, University of Szeged. Results: The majority of patients were diagnosed in advanced disease (FIGO stage III-IV) in both regions. Serous epithelial ovarian cancer was the most common cancer type among studied women in both regions. The average age of women diagnosed with ovarian cancer was 60 years; there was no significant statistical difference related to patients’ age in both studied regions. Advanced stage of ovarian cancer investigated in our study showed a moderate descending liner trend with no significant statistical difference. The results from our study were similar when compared with the epidemiological data from the literature. Conclusion: The lack of efficient screening methods is the major obstacle to improve the prognosis of women affected by this disease. Further investigations and introduction of new technologies applied to medical discoveries offers new hope for finding effective screening policies. | URI: | https://open.uns.ac.rs/handle/123456789/2557 | ISSN: | 3547310 | DOI: | 10.2298/AOO1304097M |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
1
prоvеrеnо 20.05.2023.
Prеglеd/i stаnicа
38
Prоtеklа nеdеljа
9
9
Prоtеkli mеsеc
10
10
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.